Medicines used to treat leukemia may be a new weapon in the treatment of multiple sclerosis, the researchers say. The scientists found that the drug can stop the progression of alemtuzumab disease in patients with multiple sclerosis. The study was published in the New England Journal of Medicine. Experts have not yet fully investigated the influence of the drug for the treatment of leukemia, multiple sclerosis (MS), the work of scientists in the early stages. While there is a positive effect in the treatment of MS, but experts are concerned about the manifestations of serious side effects. Ability of the drug to carry out healing effect in the brain is unprecedented, said Alasdair Coles of the University of Cambridge. Alemtuzumab - type of drug, which was developed at the University of Cambridge in the late 1970s and has long been used to treat leukemia, killing the cancer cells of the immune system. After 3 years of the study, which was attended by 334 patients with relapse of MS, experts found that the drug reduced the progression of the disease by 74% compared to conventional therapy. Experts say that the people involved in the experiment, in order to restore some functionality that was lost as. As a result of an experimental treatment is less disabled. Professionals are very encouraging results, and they are planning further studies to reduce the risk of side effects.
No comments:
Post a Comment